These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37778341)

  • 21. Low prevalence of apolipoprotein L1 gene variants in Black South Africans with hypertension-attributed chronic kidney disease
.
    Nqebelele NU; Dickens C; Dix-Peek T; Duarte R; Naicker S
    Clin Nephrol; 2019 Jan; 91(1):40-47. PubMed ID: 30369398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Apolipoprotein L1 Gene and Cardiovascular Disease.
    Robinson TW; Freedman BI
    Methodist Debakey Cardiovasc J; 2016; 12(4 Suppl):2-5. PubMed ID: 28298955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of APOL1 With Heart Failure With Preserved Ejection Fraction in Postmenopausal African American Women.
    Franceschini N; Kopp JB; Barac A; Martin LW; Li Y; Qian H; Reiner AP; Pollak M; Wallace RB; Rosamond WD; Winkler CA
    JAMA Cardiol; 2018 Aug; 3(8):712-720. PubMed ID: 29971324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways.
    Bajaj A; Ihegword A; Qiu C; Small AM; Wei WQ; Bastarache L; Feng Q; Kember RL; Risman M; Bloom RD; Birtwell DL; Williams H; Shaffer CM; Chen J; Center RG; Denny JC; Rader DJ; Stein CM; Damrauer SM; Susztak K
    Kidney Int; 2020 May; 97(5):1032-1041. PubMed ID: 32247630
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Chen TK; Surapaneni AL; Arking DE; Ballantyne CM; Boerwinkle E; Chen J; Coresh J; Köttgen A; Susztak K; Tin A; Yu B; Grams ME
    Clin J Am Soc Nephrol; 2022 May; 17(5):684-692. PubMed ID: 35474272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between
    Jiang L; Liu G; Oeser A; Ihegword A; Dickson AL; Daniel LL; Hung AM; Cox NJ; Chung CP; Wei WQ; Stein CM; Feng Q
    Elife; 2023 Oct; 12():. PubMed ID: 37882666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.
    Ng DK; Robertson CC; Woroniecki RP; Limou S; Gillies CE; Reidy KJ; Winkler CA; Hingorani S; Gibson KL; Hjorten R; Sethna CB; Kopp JB; Moxey-Mims M; Furth SL; Warady BA; Kretzler M; Sedor JR; Kaskel FJ; Sampson MG
    Nephrol Dial Transplant; 2017 Jun; 32(6):983-990. PubMed ID: 27190333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
    Gutiérrez OM; Judd SE; Irvin MR; Zhi D; Limdi N; Palmer ND; Rich SS; Sale MM; Freedman BI
    Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenome-wide analysis reveals epistatic associations between APOL1 variants and chronic kidney disease and multiple other disorders.
    Adamson WE; Noyes H; Johnson P; Cooper A; Monckton DG; Ogunsola J; Beckett-Hill G; Sullivan M; Mark P; Parekh RS; MacLeod A
    EBioMedicine; 2024 Mar; 101():105000. PubMed ID: 38360481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria.
    Abdu A; Duarte R; Dickens C; Dix-Peek T; Bala SM; Ademola B; Naicker S
    PLoS One; 2022; 17(10):e0275949. PubMed ID: 36227935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes.
    Elliott MD; Marasa M; Cocchi E; Vena N; Zhang JY; Khan A; Krishna Murthy S; Bheda S; Milo Rasouly H; Povysil G; Kiryluk K; Gharavi AG
    J Am Soc Nephrol; 2023 May; 34(5):909-919. PubMed ID: 36758113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of Kidney Function Decline Associated with APOL1 Genotypes: Results from AASK.
    Tin A; Grams ME; Estrella M; Lipkowitz M; Greene TH; Kao WHL; Li L; Appel LJ
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1353-1359. PubMed ID: 27230965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.
    Tin A; Grams ME; Maruthur NM; Astor BC; Couper D; Mosley TH; Fornage M; Parekh RS; Coresh J; Kao WH
    Clin J Am Soc Nephrol; 2015 May; 10(5):784-90. PubMed ID: 25887069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Rakic JM; Pullinger CR; Van Blarigan EL; Movsesyan I; Stock EO; Malloy MJ; Kane JP
    J Am Heart Assoc; 2023 Dec; 12(24):e030796. PubMed ID: 38084718
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOL1 risk variants, race, and progression of chronic kidney disease.
    Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
    N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of
    Chen TK; Katz R; Estrella MM; Post WS; Kramer H; Rotter JI; Tayo B; Mychaleckyj JC; Wassel CL; Peralta CA
    J Am Heart Assoc; 2020 Sep; 9(17):e017039. PubMed ID: 32851884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.
    Chang JH; Husain SA; Santoriello D; Stokes MB; Miles CD; Foster KW; Li Y; Dale LA; Crew RJ; Cohen DJ; Kiryluk K; Gharavi AG; Mohan S
    Am J Kidney Dis; 2019 Jan; 73(1):134-139. PubMed ID: 30054024
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Zhang JY; Wang M; Tian L; Genovese G; Yan P; Wilson JG; Thadhani R; Mottl AK; Appel GB; Bick AG; Sampson MG; Alper SL; Friedman DJ; Pollak MR
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3446-3451. PubMed ID: 29531077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.